Walvax Biotechnology Co., Ltd. (300142.SZ)

CNY 13.07

(0.31%)

Annual Balance Sheets

(In CNY)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 15.58 Billion 15.32 Billion 13.67 Billion 9.63 Billion 7.01 Billion 7.23 Billion
Total Current Assets 8.73 Billion 8.94 Billion 7.68 Billion 4.78 Billion 3.44 Billion 4.13 Billion
Cash And Short Term Investments 4.36 Billion 3.87 Billion 3.44 Billion 1.96 Billion 2.38 Billion 2.48 Billion
Cash and Cash Equivalents 4.36 Billion 3.87 Billion 3.44 Billion 1.96 Billion 2.38 Billion 2.48 Billion
Short Term Investments - -38.15 Million -45.05 Million -48.19 Million -47.52 Million -40.23 Million
Net Receivables 3.31 Billion 4.02 Billion 3.33 Billion 2.33 Billion 734.44 Million 1.41 Billion
Inventory 1.03 Billion 995.81 Million 873.59 Million 483.55 Million 313.04 Million 236.28 Million
Other Current Assets 18.63 Million 58.89 Million 28.76 Million 4.3 Million 14.98 Million 503.39 Thousand
Total Non-Current Assets 6.85 Billion 6.37 Billion 5.99 Billion 4.85 Billion 3.57 Billion 3.09 Billion
Net PPE 4.01 Billion 3.16 Billion 2.6 Billion 1.59 Billion 1.38 Billion 1.3 Billion
Good Will And Intangible Assets 1.51 Billion 1.46 Billion 1.47 Billion 1.18 Billion 1.03 Billion 860.89 Million
Good Will 33.65 Million 33.65 Million 33.65 Million 33.65 Million 33.65 Million 33.65 Million
Intangible Assets 1.48 Billion 1.43 Billion 1.44 Billion 1.15 Billion 1 Billion 827.23 Million
Long-Term Investments 1.08 Billion 1.32 Billion 1.53 Billion 1.65 Billion 909.79 Million 791.79 Million
Tax Assets 103.44 Million 116.8 Million 168 Million 138.55 Million 91.6 Million 44.51 Million
Other Non Current Assets 137.86 Million 305.95 Million 206.43 Million 292.85 Million 147.52 Million 100.37 Million
Other Assets - - - 1.00 - 1.00
Total Liabilities 3.77 Billion 4.33 Billion 3.67 Billion 1.79 Billion 1.35 Billion 1.98 Billion
Total Current Liabilities 3.2 Billion 3.5 Billion 3.23 Billion 1.42 Billion 1.08 Billion 1.53 Billion
Account Payables 1.77 Billion 1.83 Billion 1.25 Billion 607.79 Million 276.73 Million 251.79 Million
Tax Payables 14.13 Million 45.05 Million 32.12 Million 98.04 Million 32.96 Million 87.23 Million
Short Term Debt 383.58 Million 120.53 Million 314.6 Million 40 Million -24.66 Million 105 Million
Deferred Revenue 30.47 Million 48.77 Million 929.75 Million 298.16 Million 24.66 Million 87.23 Million
Other Current Liabilities 1.01 Billion 1.5 Billion 732.89 Million 476.01 Million 811.72 Million 1.09 Billion
Total Non Current Liabilities 566.27 Million 829.62 Million 439.91 Million 368.44 Million 263.29 Million 445.45 Million
Long-Term Debt 434.89 Million 341.97 Million 1.06 Million 2.03 Million - 180.93 Million
Deferred Revenue Non Current 423.32 Million 404.52 Million 344.29 Million 256.17 Million 223.13 Million 184.55 Million
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities -360.65 Million 1.00 1.00 -2.03 Million 1.00 1.00
Other Liabilities -0.00 1.00 1.00 - - -
Total Equity 11.39 Billion 10.98 Billion 9.99 Billion 7.84 Billion 5.66 Billion 5.25 Billion
Stock Holders Equity 9.34 Billion 9.08 Billion 8.48 Billion 6.54 Billion 4.86 Billion 4.57 Billion
Common Stock 1.6 Billion 1.6 Billion 1.6 Billion 1.54 Billion 1.53 Billion 1.53 Billion
Retained Earnings 2.9 Billion 2.49 Billion 1.81 Billion 1.47 Billion 509.52 Million 434.53 Million
Accumulated other comprehensive income 776.48 Million 777.81 Million 845.49 Million 769.97 Million 427.8 Million 352.52 Million
Common Stock Equity 9.34 Billion 9.08 Billion 8.48 Billion 6.54 Billion 4.86 Billion 4.57 Billion
Capital Lease Obligation 20.59 Million 27.73 Million 1.06 Million 2.03 Million - 180.93 Million
Total Investments 1.08 Billion 1.29 Billion 1.49 Billion 1.6 Billion 862.27 Million 751.55 Million
Total Debt 839.07 Million 462.51 Million 315.66 Million 40 Million - 105 Million
Net Debt -3.52 Billion -3.41 Billion -3.12 Billion -1.92 Billion -2.38 Billion -2.37 Billion

Balance Sheet Charts